XTL Biopharmaceuticals soars after all-stock Psyga Bio acquisition announcement

By: Quiver PriceTracker

Posted: 1 day, 23 hours ago / April 29, 2026 3:50 p.m. UTC

XTLB

XTL Biopharmaceuticals Ltd. (XTLB) is up 70.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to XTLB’s announcement of a transformational acquisition that pivots the company into the psychedelic-therapeutics space, alongside a related financing commitment. For a micro-cap biotech, a deal that reshapes the pipeline and narrative can trigger sharp, momentum-driven re-pricing and high volatility.

Details:

XTLB signed a definitive share purchase agreement to acquire 100% of Psyga Bio Ltd., a psychedelic and functional mushroom-focused biotech with a GMP-ready manufacturing facility and a stated pipeline of seven approved Phase 2a human clinical trials.

The consideration is all-stock: Psyga shareholders are set to receive ADSs representing 40% of XTLB’s post-issuance equity, with potential additional ADS issuance tied to three milestones (each milestone representing up to 10% based on terms disclosed).

The transaction requires XTLB shareholder approval and is also framed as dependent on maintaining the company’s Nasdaq listing status; a change in listing status could force a re-evaluation of terms.

XTLB also disclosed a commitment for up to $1.5 million of investment via a private placement intended to close alongside the acquisition.

Sources:

SEC, GlobeNewswire, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$XTLB Hedge Fund Activity

We have seen 5 institutional investors add shares of $XTLB stock to their portfolio, and 3 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NOKED ISRAEL LTD added 149,166 shares (+300.0%) to their portfolio in Q4 2025, for an estimated $86,516
CITADEL ADVISORS LLC added 75,866 shares (+inf%) to their portfolio in Q4 2025, for an estimated $44,002
RHUMBLINE ADVISERS added 25,793 shares (+597.8%) to their portfolio in Q4 2025, for an estimated $14,959
SMARTHARVEST PORTFOLIOS, LLC added 13,351 shares (+inf%) to their portfolio in Q1 2026, for an estimated $32,175
XTX TOPCO LTD added 10,238 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,938
GAMMA INVESTING LLC removed 3,222 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $7,765
MORGAN STANLEY removed 763 shares (-30.5%) from their portfolio in Q4 2025, for an estimated $442

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.